This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Which Aristocrats Etf Grows Best Over 10 Years
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articles
Counterintuitive Truth That Should Frighten Market Timers
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
Redwire Corporation Stock Keeps Rising: Key Drivers
Investors are watching Redwire as its stock keeps rising, driven by backlog gains and contract momentum. This guide b...
Nu Holdings Already Has More Customers: Revenue per User in Focus
Nu Holdings already has more customers than many U.S. banks. The bigger question for investors is: how much revenue c...
Deceptive Advertising! Claims Novo in GLP-1 Lawsuit Fallout
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Many Retirees Underestimating Healthcare Use, Not Just Costs
New studies indicate that in retirement, healthcare usage grows faster than budgets assume. Analysts warn that many r...
Lisa Believes Deal with Meta Could Drive Triple-Digit Growth
A rumored alliance between AMD and Meta Platforms could reshape AI hardware and software ecosystems. This article exa...
Bitcoin Been Declared Dead: What History Teaches Investors
For years, headlines have proclaimed Bitcoin dead. Yet the asset keeps proving skeptics wrong. This article breaks do...
Goldman Sachs Just Added UnitedHealth: Why It Could Soar
When a top bank places a stock on its conviction list, it moves markets. This article explains why Goldman Sachs just...
Case Against Buying Ford: Risks and Rewards for the Stock
Ford stock has momentum, but the decision to buy isn’t straightforward. This article breaks down the case for and aga...
This Stock Will Dominate the Second Half of 2026, Investors
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
Still Like Stock, This: Berkshire's New Direction with Abel
Greg Abel’s early moves at Berkshire Hathaway hint at a new rhythm for the conglomerate. This article breaks down wha...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status